Whether you're considering Wegovy, Zepbound, Ozempic, Mounjaro, bariatric surgery, or the Medicare GLP-1 Bridge Program, our insurance specialists are here to help you understand your coverage before treatment begins
A dual GLP-1/GIP receptor agonist An ideal antidiabetic medication should present proven efficacy in lowering elevated glucose levels, promote weight loss, have low risk of hypoglycemia and offer cardiovascular benefits [18]
External resources ACOG: Exercise After Pregnancy - Official guidelines from the American College of Obstetricians and Gynecologists on returning to physical activity postpartum CDC: Postpartum Depression - Resources for identifying and addressing postpartum mood disorders that may affect treatment decisions LactMed Database - National Library of Medicine database for checking medication safety during breastfeeding, including GLP-1 receptor agonist entries NIDDK: Gestational Diabetes - National Institute of Diabetes and Digestive and Kidney Diseases information on gestational diabetes and long-term metabolic health WHO: Breastfeeding Guidelines - World Health Organization guidance on breastfeeding nutrition and health considerations For new mothers serious about reclaiming their health safely, SeekPeptides offers evidence-based protocols, dosing calculators, and a community of researchers who understand the unique demands of postpartum recovery
Injectable GLP-1 drugs have demonstrated 15% to 20% weight loss in trials
